SynGAP Research Fund
Overview
A 501(c)(3) public charity and family-led organization dedicated to improving the quality of life for SYNGAP1 patients. It is the largest non-governmental funder of SYNGAP1 research, awarding grants to researchers and clinicians to accelerate the development of treatments, therapies, and support systems for SYNGAP1-related disorders.
Portfolio Companies
5
Website
curesyngap1.orgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CAMP4 | Sep 2025 | Private Placement | Co-investor |
| Axonis Therapeutics | Sep 2024 | Grant | Co-investor |
| 4M Therapeutics | Nov 2024 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is SynGAP Research Fund based?
SynGAP Research Fund is headquartered in Palo Alto, California, United States.
When was SynGAP Research Fund founded?
Founding year information for SynGAP Research Fund is not publicly available.
How many portfolio companies does SynGAP Research Fund have?
SynGAP Research Fund has 5 portfolio companies in Caplight's dataset.
What are some companies in SynGAP Research Fund's portfolio?
Portfolio companies visible on Caplight include CAMP4, Axonis Therapeutics, 4M Therapeutics.
What was SynGAP Research Fund's most recent investment shown here?
SynGAP Research Fund's most recent investment in this portfolio sample was in CAMP4 in 2025.
What sectors does SynGAP Research Fund focus on?
SynGAP Research Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does SynGAP Research Fund focus on?
SynGAP Research Fund typically invests at the MultiStage stage.